BLÁHOVÁ, Lucie, Jan KUTA, Lenka DOLEŽALOVÁ, Šárka KOZÁKOVÁ, Tereza HOJDAROVÁ and Luděk BLÁHA. The efficiency of antineoplastic drug contamination removal by widely used disinfectants-laboratory and hospital studies. International Archives of Occupational and Environmental Health. New York: Springer, 2021, vol. 94, No 7, p. 1687-1702. ISSN 0340-0131. Available from: https://dx.doi.org/10.1007/s00420-021-01671-5.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The efficiency of antineoplastic drug contamination removal by widely used disinfectants-laboratory and hospital studies
Authors BLÁHOVÁ, Lucie (203 Czech Republic, belonging to the institution), Jan KUTA (203 Czech Republic, belonging to the institution), Lenka DOLEŽALOVÁ (203 Czech Republic), Šárka KOZÁKOVÁ (203 Czech Republic), Tereza HOJDAROVÁ (203 Czech Republic, belonging to the institution) and Luděk BLÁHA (203 Czech Republic, guarantor, belonging to the institution).
Edition International Archives of Occupational and Environmental Health, New York, Springer, 2021, 0340-0131.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30304 Public and environmental health
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.851
RIV identification code RIV/00216224:14310/21:00120136
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1007/s00420-021-01671-5
UT WoS 000630269700001
Keywords in English Occupational exposure; Hazardous drugs; Surface contamination; Disinfectants; Antineoplastic drugs
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 8/12/2021 13:12.
Abstract
Objective Antineoplastic drugs (ADs) pose risks to healthcare staff. Surface disinfectants are used in hospitals to prevent microbial contamination but the efficiency of disinfectants to degrade ADs is not known. We studied nine disinfectants on ten ADs in the standardized laboratory and realistic in situ hospital conditions. Methods A survey in 43 hospitals prioritized nine most commonly used disinfections based on different ingredients. These were tested on inert stainless steel and in situ on contaminated hospital flooring. The effects against ten ADs were studied by LC-MS/MS (Cyclophosphamide CP; Ifosfamide IF; Capecitabine CAP; Sunitinib SUN; Methotrexate MET; Doxorubicin DOX; Irinotecan IRI; Paclitaxel PX; 5-Fluorouracil FU) and ICP-MS (Pt as a marker of platinum-based ADs). Results Monitoring of the floor contamination in 26 hospitals showed that the most contaminated are the outpatient clinics that suffer from a large turnover of staff and patients and have limited preventive measures. The most frequent ADs were Pt, PX, FU and CP with maxima exceeding the recommended 1 ng/cm(2) limit by up to 140 times. IRI, FU, MET, DOX and SUN were efficiently removed by hydrolysis in clean water and present thus lower occupational risk. Disinfectants based on hydrogen peroxide were efficient against PX and FU (> 70% degradation) but less against other ADs, such as carcinogenic CP or IF, IRI and CAP. The most efficient were the active chlorine and peracetic acid-based products, which however release irritating toxic vapors. The innovative in situ testing of ADs previously accumulated in hospital flooring showed highly problematic removal of carcinogenic CP and showed that alcohol-based disinfectants may mobilize persistent ADs contamination from deeper floor layers. Conclusion Agents based on hydrogen peroxide, peracetic acid, quaternary ammonium salts, glutaraldehyde, glucoprotamine or detergents can be recommended for daily use for both disinfection and AD decontamination. However, they have variable efficiencies and should be supplemented by periodic use of strong chlorine-based disinfectants efficient also against the carcinogenic and persistent CP.
Links
LM2018121, research and development projectName: Výzkumná infrastruktura RECETOX (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR, RECETOX RI
NV18-09-00188, research and development projectName: Monitoring expozice cytotoxickým léčivům u pracovníků ve zdravotnictví a rodinných příslušníků onkologických pacientů, analýza rizik, zpracování doporučených postupů
Investor: Ministry of Health of the CR
PrintDisplayed: 25/7/2024 22:16